In one study, ST-elevation myocardial infarction (STEMI) patients showed higher serum MMP-9 and MMP-9/TIMP-1 values compared to subjects without coronary artery disease (CAD), but they had no prognostic value in a 2-year follow-up [15]. This evidence concerns the gene MMP9 and coronary artery disorder.